A REVIEW ON OVERVIEW OF AN ESOPHAGEAL CANCER

*Dr. Amratha Johnson, Dr. Axa Mariam Babu, Dr. Bobas Jose and Dr. Beulah Mariam Jacob

ABSTRACT

Esophageal cancer is the sixth leading cause of cancer-related mortality and the seventh most common type of cancer overall. The global treatment trends and survival rates for esophageal cancer are included in our study's overview. This study examines every case of esophageal cancer that has been diagnosed in the last few years. Both squamous cell carcinoma (SCC) and adenocarcinoma (AC) are the two most common kinds of esophageal cancer, although they each have different causes. The standard treatment for unresectable, locally advanced esophageal cancer is now concurrent chemoradiation, based on the groundbreaking Radiation Therapy Oncology Group trial 85-01, which showed a 26% 5-year survival rate with Cisplatin, 5FU, and concurrent radiation. That being said, compared to those receiving radiation therapy, there was a higher 3-year mortality rate among the surgical patients. Furthermore, compared to participants receiving radiation therapy, there was a higher 3-year mortality rate among those who had undergone surgery. For esophageal malignancies, surgery is the recommended course of treatment; in cases where surgery is not appropriate, radiotherapy is a local alternate intervention.

Keywords: Esophageal cancer, Squamous cell carcinoma (SCC), Adenocarcinoma (AC), Introduction, Overview.